Keryx Biopharmaceuticals, Inc.
USD3.36
+0.00 (+0.00%)
IPO Date
2000-07-28
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Open
$3.36
Prev. Close
$3.36
Day Low
$3.36
Day High
$3.36
52W Low
$2.47
52W High
$5.98
| 35,582,335 |
| $4.63 |
| 13 Dec 2018 | BAUPOST GROUP LLC/MA | director, 10 percent owner: | M-Exempt | Disposed | 0 | $4.63 |
| 13 Dec 2018 | BAUPOST GROUP LLC/MA | director, 10 percent owner: | D-Return | Disposed | 65,374,013 | $0.00 |
| 13 Dec 2018 | Enyedy Mark J | director | D-Return | Disposed | 10,000 | $8.94 |
| 13 Dec 2018 | Enyedy Mark J | director | D-Return | Disposed | 80,000 | $0.00 |
| 13 Dec 2018 | Holmes Scott A | Chief Financial Officer | D-Return | Disposed | 162,956 | $8.94 |
| 13 Dec 2018 | Holmes Scott A | Chief Financial Officer | D-Return | Disposed | 902,500 | $0.00 |
| 13 Dec 2018 | Regan Daniel Paul | director | D-Return | Disposed | 60,000 | $8.94 |
| 13 Dec 2018 | Regan Daniel Paul | director | D-Return | Disposed | 200,000 | $0.00 |